MME and acute lymphoblastic leukemia: Miser et al. [61] treated 31 children with acute lymphoblastic leukemia (ALL), 14 children with acute non-lymphoblastic leukemia (ANLL) in relapse, and one child with chronic myelogenous leukemia (CML) in blast crisis (CALLA negative) with indicine N-oxide in a Phase II study.